Kalvista Pharmaceuticals Inc (KALV NASDAQ) stock market data APIs
$26.7142
0.03(0.1%)
as of May 5, 2026
Try our APIs with
free plan!
Kalvista Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
KalVista Pharmaceuticals, Inc., a biopharmaceutical company, develops oral therapies for individuals for rare diseases with unmet needs. Its lead product candidate is EKTERLY, a fast-acting potent inhibitor of plasma kallikrein for the treatment of acute attacks of hereditary angioedema (HAE). The company is also developing is developing an orally disintegrating tablet formulation; KONFIDENT-KID for pediatric use with HAE; KONFIDENT; and KONFIDENT-S to evaluate sebetralstat and ODT formulation in adolescent and adult patients. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts.
Prev. Close
26.7142
Open
26.9008
High
26.9464
Low
26.6945
52 wk Range
9.83-26.76
Market Cap
1 420 M
Shares Outstanding
53 168 K
Revenue
73 617 K
EPS
0.94
Beta
-0.121
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Kalvista Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Kalvista Pharmaceuticals Inc data using free add-ons & libraries
Get Kalvista Pharmaceuticals Inc Fundamental Data
Kalvista Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 73 617 K
- EBITDA: -164 816 992
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Kalvista Pharmaceuticals Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-03-25
- EPS/Forecast: -0.5263
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Kalvista Pharmaceuticals Inc News
New
Key deals this week: Organon, ARC Resources, Nebius, Eli Lilly and more
[M A - concept waiting for mergers and acquisitions.3D rendering on yellow background.] fengdr Here's a list of key deals reported across sectors this week: * Esperion Therapeutics (ESPR [https://...
Stock Market Today, April 29: KalVista Pharmaceuticals Surges on Chiesi Group Acquisition Announcement
KalVista Pharmaceuticals(NASDAQ:KALV), a developer of oral therapies for rare diseases, closed Wednesday at $26.67, up 38.62%. The stock moved higher after news that Italy’s Chiesi Group will acquir...
Sector Update: Health Care Stocks Fall Late Afternoon
Health care stocks declined late Wednesday afternoon, with the NYSE Health Care Index down 0.6% and PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscrip...
KalVista Scores $1.9 Billion Takeover Deal; Why A Key Rival Jumped Too
Shares of KalVista Pharmaceuticals catapulted Wednesday on a $1.9 billion takeover offer from Italy's Chiesi Group. Continue Reading
Get Kalvista Pharmaceuticals Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
